BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03532451-completion@plaintrial.com
DTSTAMP:20261027T173258Z
DTSTART;VALUE=DATE:20221005
SUMMARY:Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Ci
 splatin-Ineligible Muscle-Invasive Bladder Cancer — estimated completion
  date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03532451
URL:https://plaintrial.com/trial/NCT03532451
END:VEVENT
END:VCALENDAR